Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard C. Becker
Frederick A. Spencer

Showing results (1-10 of 463) with videos related to

Pageof 47
Sort By:
Current Interventional Cardiology Reports|August 4, 2001
Moving Up the Coagulation Cascade: Potential Factor X Inhibition for Percutaneous Coronary InterventionRichard C. Becker, Frederick A. Spencer
Journal of Thrombosis and Thrombolysis|October 24, 2003
Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitorYou fu Li, Frederick A Spencer, Richard C Becker
American Heart Journal|March 30, 2002
Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibitionYou Fu Li, Frederick A Spencer, Richard C Becker
Journal of Thrombosis and Thrombolysis|April 26, 2003
Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistanceYouFu Li, Miguel Rodriquez, Frederick A Spencer, et al.
Journal of General Internal Medicine|July 1, 2006
The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolismFrederick A Spencer, Cathy Emery, Darleen Lessard, et al.
Journal of Thrombosis and Thrombolysis|April 9, 2005
Vascular endothelial tissue factor pathway inhibitor kinetics in culture following exposure to DX-9065a--a selective and direct factor Xa inhibitorRichard C Becker, John H Alexander, Youfu Li, et al.
American Heart Journal|June 1, 2002
Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromesRichard C Becker, Frederick A Spencer, Michael Gibson, et al.
Current Cardiology Reports|July 1, 2005
Heart failure and shock complicating acute coronary syndromesFrederick A Spencer, Theo Meyer
Circulation|June 20, 2003
Risk factors for venous thromboembolismFrederick A Anderson, Frederick A Spencer
Journal of Thrombosis and Thrombolysis|August 17, 2021
Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's page seriesRichard C Becker
Pageof 47

Showing results (1-10 of 463) with videos related to

Sort By:
Pageof 47
Current Interventional Cardiology Reports|August 4, 2001
Moving Up the Coagulation Cascade: Potential Factor X Inhibition for Percutaneous Coronary InterventionRichard C. Becker, Frederick A. Spencer
Journal of Thrombosis and Thrombolysis|October 24, 2003
Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitorYou fu Li, Frederick A Spencer, Richard C Becker
American Heart Journal|March 30, 2002
Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibitionYou Fu Li, Frederick A Spencer, Richard C Becker
Journal of Thrombosis and Thrombolysis|April 26, 2003
Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistanceYouFu Li, Miguel Rodriquez, Frederick A Spencer, et al.
Journal of General Internal Medicine|July 1, 2006
The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolismFrederick A Spencer, Cathy Emery, Darleen Lessard, et al.
Journal of Thrombosis and Thrombolysis|April 9, 2005
Vascular endothelial tissue factor pathway inhibitor kinetics in culture following exposure to DX-9065a--a selective and direct factor Xa inhibitorRichard C Becker, John H Alexander, Youfu Li, et al.
American Heart Journal|June 1, 2002
Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromesRichard C Becker, Frederick A Spencer, Michael Gibson, et al.
Current Cardiology Reports|July 1, 2005
Heart failure and shock complicating acute coronary syndromesFrederick A Spencer, Theo Meyer
Circulation|June 20, 2003
Risk factors for venous thromboembolismFrederick A Anderson, Frederick A Spencer
Journal of Thrombosis and Thrombolysis|August 17, 2021
Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's page seriesRichard C Becker
Pageof 47